Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02875704 · ClinicalTrials.gov registry record
Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy
A clinical trial, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- 77
- Enrollment target
NCT02875704: Clinical Trial study, sponsored by Johns Hopkins University.
NCT02875704 is a clinical trial that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 77 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02875704 was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- 77 participants
- Enrollment target
Study Summary
In this study, markers of oxidative stress will be measured in the aqueous humour of stargardt disease, age related macular degeneration and diabetic retinopathy patients compared to controls.
Primary Outcome
Baseline = Day of clinic visit for stargardt disease, AMD, DR patients and day of surgery for patients undergoing cataract surgery. No follow up is required.
Interventions
- OTHER Anterior Chamber (AC) Tap
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2017-01-03 |
| Est. Completion | 2022-09-22 |
Why NCT02875704 stopped before completion
NCT02875704 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 77 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Anterior Chamber (AC) Tap is the first listed.
NCT02875704 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02875704 about?
NCT02875704 is a clinical study titled "Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy". In this study, markers of oxidative stress will be measured in the aqueous humour of stargardt disease, age related macular degeneration and diabetic retinopathy patients compared to controls.
What is the current status of trial NCT02875704?
This trial is currently terminated. The enrollment target is 77 participants. The study started on 2017-01-03. Estimated completion is 2022-09-22.
What interventions are being tested in trial NCT02875704?
The interventions under investigation include: Anterior Chamber (AC) Tap (OTHER).
Who is sponsoring clinical trial NCT02875704?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02127398 · 77 participants · Phase 2
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
- NCT04159103 · 77 participants · Phase 1
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- NCT04683003 · 77 participants · Phase 3
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
- NCT05004116 · 77 participants · Phase 1
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI